Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 592,116 |
|
|||||
| News | - | ||||||
| Day High | 0.8582 | Low High |
|||||
| Day Low | 0.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cartesian Therapeutics Inc | RNAC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0511 | 6.97% | 0.7839 | 14:53:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7261 | 0.70 | 0.8582 | 0.7328 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,927 | 592,116 | $ 0.7480542 | $ 442,935 | - | 0.6648 - 1.42 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:55:40 | 1 | $ 0.7994 | USD |
Cartesian Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 117.96M | 155.20M | - | 110.78M | 35.38M | 0.23 | 3.33 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cartesian Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNAC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.12 | 1.35 | 0.6648 | 0.9391325 | 1,988,255 | -0.3361 | -30.01% |
| 1 Month | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
| 3 Months | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
| 6 Months | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
| 1 Year | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
| 3 Years | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
| 5 Years | 0.8065 | 1.42 | 0.6648 | 1.03 | 1,403,143 | -0.0226 | -2.8% |
Cartesian Therapeutics Description
| Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. |
